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ReviewDuring the past 15 years mass spectrometry (MS)-based
analyses have become established as the method of
choice for direct protein identification and measure-
ment. Owing to the remarkable improvements in the
sensitivity and resolution of MS instruments, this tech-
nology has revolutionised the opportunities available for
the system-wide characterisation of proteins, with wide
applications across virtually the whole of cell biology. In
this article we provide a perspective on the current state
of the art and discuss how the future of cell biology
research may benefit from further developments and
applications in the field of MS and proteomics, highlight-
ing the major challenges ahead for the community in
organising the effective sharing and integration of the
resulting data mountain.
Introduction
In 1997 a commentary in Trends in Cell Biology, entitled
‘Cell Biology and the genome projects – a concerted strate-
gy for characterizing multiprotein complexes by using
mass spectrometry’ [1], reviewed some of the exciting
technical developments that had allowed the use of MS
to identify proteins, particularly when used in concert with
the growing collection of DNA sequence information. At
that time this largely comprised libraries of expressed
sequence tag (EST) clones. It highlighted the promise this
held for cell biology, showing how MS could greatly en-
hance the efficiency and sensitivity of protein detection
over previous methods, and hence facilitate the direct
analysis of proteins and multiprotein complexes involved
in biological responses and regulatory mechanisms. This
article, which pre-dated completion of the human genome
project, also anticipated that MS-based proteomics would
grow to provide the method of choice for protein analysis
and for deciphering the functions of open reading frames
(ORFs) as more genome sequences became available.
Fifteen years later, the efficient detection of cell proteins
using MS has indeed become routine, and it is hard to
imagine conducting biological research without access to
complete genome sequences. The speed and resolution of
mass spectrometers has increased dramatically, and we0962-8924/$ – see front matter
 2013 Elsevier Ltd. All rights reserved. http://dx.doi.org/10.1016/j.tcb.2013.10.010
Corresponding author: Lamond, A.I. (a.i.lamond@dundee.ac.uk).now have access to powerful software for automated anal-
ysis of raw spectra [2–5]. In this article we discuss how
modern MS-based proteomics can be used to study many
areas of cell biology. We also look ahead to the next 15
years, illustrating new opportunities for advancing cell and
molecular biology using MS-based proteomic strategies.
One of the key future challenges we foresee is the need for
the cell biology community to develop a coherent strategy,
as well as new computational tools, to cope with the effec-
tive integration, analysis, and sharing of the emerging
proteomics ‘data mountain’.
From genomes to multi-dimensional proteomes
Now that the human genome is sequenced, together with the
genomes of most common model organisms, it is tempting to
assume that cell ‘proteomes’ – in other words a detailed
inventory of the proteins present – can be deduced simply by
reference to ORFs in the corresponding DNA sequence. In
practice the situation is much more complex. For example,
in higher organisms there is usually no simple ‘one-to-one’
relationship between genes and proteins. Instead, there are
‘one-to-many’ relationships, primarily because a single ORF
can encode multiple protein isoforms.
A range of mechanisms, including alternative splicing of
mRNA precursors, cleavage and processing of polypeptide
chains, and post-translational modifications (PTMs), con-
tribute to generating multiple protein isoforms, with dis-
tinct or overlapping functions. To complicate the situation
further, the same polypeptide chains can also form distinct
functional pools of protein that are regulated independent-
ly. For example, the catalytic subunit of protein phospha-
tase 1 (PP1) forms many separate protein phosphatase
enzymes by binding to an array of different targeting
subunits. These distinct and independently regulated
forms of protein phosphatases act on different substrates
in different subcellular locations [6].
Thus, although genomic sequences reveal the protein-
coding potential for a given organism or species, they do not
reliably inform us about the many protein properties that
correspond to the variables that are usually modulated
during biological responses and regulatory mechanisms.
The dynamic nature of these protein properties also means
that they cannot be deduced from a static DNA genome
sequence alone, either for a given cell cycle stage or at
different times during response to a cell signalling event.
Furthermore, in most cases measurements of transcript
levels will not reveal dynamic protein properties, such
as PTM patterns, interaction partners, or subcellularTrends in Cell Biology, April 2014, Vol. 24, No. 4 257
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Figure 1. Bottom-up proteomics workflow. ‘Proteomics’ is used throughout as an
umbrella term for the large-scale identification and analysis of proteins. We focus
here specifically on the analysis of proteins by mass spectrometry (MS), because this
has emerged as by far the most widely used and efficient current technology. The
standard ‘bottom-up’ proteomics workflow illustrated involves isolating proteins
from either cells or tissues, digesting them to peptides using one or more proteases
(e.g., trypsin), then separating the resulting peptide mixtures by nano-LC (nano-
liquid chromatography) and identifying the peptides in a mass spectrometer. The
resulting peptide identifications are subsequently mapped to proteins, using
genomic information to identify open reading frames (ORFs) that encode these
peptides. Although the MS analysis actually measures peptides, most subsequent
data analysis in cell biology experiments interprets the results in terms of the inferred
protein identifications, and the quality of the data can vary according to how many
peptides were detected for each protein. Usually a minimum of at least two separate
peptides are required to confirm protein identification.
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pools of protein. Indeed, recent studies indicate that tran-
script levels often do not reliably reflect the abundance of
the cognate protein [7]. Thus, crucial information on pro-
tein expression and interactions, which is central to a
detailed understanding of cell phenotypes and molecular
mechanisms, will not emerge from analysis of genomic and
transcriptomic datasets alone. Therefore, to evaluate how
protein properties vary over time during cellular responses
one must directly and empirically measure and quantitate
proteins at multiple time-points. The method of choice for
such direct protein measurement is now ‘bottom-up’ MS-
based proteomics (Figure 1).
Time-lapse proteomics – quantitating proteome
responses
It is clear that proteomes change significantly in real time,
making them highly dynamic. For example, the changing
nature of an organelle proteome was demonstrated by258comparing the protein composition of nucleoli isolated
from cells following drug treatment to inhibit transcrip-
tion [8,9]. This required multiple MS analyses, using
nucleoli purified from cells isolated under different con-
ditions and at different time-points, thereby creating a
‘time-lapse’ proteomics view of the response. The synap-
tosomal proteome provides another example because it
was shown to change during postnatal development using
the multi-dimensional protein identification technology
(MudPIT) [10]. With improvements in the speed and reso-
lution of MS workflows it is now possible to perform such
time-lapse proteomics studies to capture not only protein
identities but also a wide range of protein properties for
many thousands of cell proteins at multiple time-points.
Expanding such studies on a system-wide scale, encom-
passing measurement of a large fraction of the expressed
cell proteome, promises to provide unprecedented new
insights into many of the molecular mechanisms involved
in cellular regulation. However, collecting multi-dimen-
sional data at multiple time-points results in an explosion
in the volume of proteomics data, and this creates chal-
lenges in effective data management.
One of the most successful MS-based strategies for time-
lapse proteomics has been development of isotope-labelling
methods that facilitate the quantitation and differential
comparison of proteins, either at different times and/or
under different conditions. This is a flexible approach for
comparing a control sample with one or more varied ex-
perimental conditions, such as changes in protein levels
and PTMs in response to drug treatment, viral infection,
hormone stimulation, cell differentiation, or oncogene ac-
tivation (Figure 2A). It has also been adapted to provide a
quantitative assay for evaluation of protein properties,
including subcellular protein localisation, rates of protein
synthesis and degradation, and for discrimination of spe-
cific from non-specific protein interaction partners [11–14].
Isotope-labelling strategies
Some of the first examples of using metabolic labelling to
incorporate stable isotopes into proteins for quantitative
proteomics took advantage of labelling methods previously
used by structural biologists for nuclear magnetic reso-
nance (NMR) analyses [15,16]. Subsequently, the differen-
tial isotope labelling strategy termed SILAC (stable
isotope labelling with amino acids in cell culture) [17],
which involves metabolic labelling of proteins in vivo,
has been widely applied to cell biology. Thus, translation
of proteins incorporates amino acids that have the natural
‘light’ isotopes of carbon, nitrogen, or hydrogen substituted
with heavier isotopic forms such as 13C, 15N, and/or 2H.
Usually this is carried out using isotope-substituted forms
of arginine and/or lysine because subsequent trypsin di-
gestion of the isolated proteins for MS analysis, which
cleaves at basic residues, generates peptides with a single
labelled amino acid, thereby simplifying analysis and
quantification. The distinct ‘light’, ‘medium’, and ‘heavy’
forms of each peptide detected by MS reflect the relative
amounts of the corresponding protein in each of the three
‘isotopically encoded’ cell populations.
The light, medium, and heavy forms of the same pep-
tides can be resolved and quantitated simultaneously
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Figure 2. Isotope labelling strategies. Isotope labelling methods such as SILAC (stable isotope labelling with amino acids in cell culture) and iTRAQ (isobaric tag for relative
and absolute quantitation) provide a convenient approach for the quantitative proteomic comparison of two or more experimental variables by introducing tags that can be
discriminated in the mass spectrometer to distinguish and measure the proteins from each separate condition or cell sample. (A) Isotope labelling is a highly flexible
strategy that can be adapted to identify and compare protein interaction partners, subcellular protein localisation, drug treatment, viral infection, and effects of genotype
etc. (B) A multispectral image (MSI) spectrum of a peptide selected in a triple SILAC experiment. In the illustrated example the m/z signal from the peptide (x axis) is
separated in the spectrum into three clusters of signals, corresponding to the ‘light’, ‘medium’, and ‘heavy’ isotopic forms. The measured ion intensities (y axis) for each
isotopic form of the peptide are then compared, and these reflect the corresponding property of the protein from which the peptide was derived in each cell state. In most
cases, data are subsequently represented by averaging the separate values measured for all peptides identified for each protein.
Review Trends in Cell Biology April 2014, Vol. 24, No. 4within the same sample by MS, thereby reducing potential
sources of experimental variation between samples. A
similar strategy has also been applied to a range of model
organisms including yeast, bacteria, nematodes, plants,
and mice [10,18–20]. We anticipate that further studies
using whole-organism metabolic labelling will provide im-
portant new opportunities for linking quantitative proteo-
mics data with physiology and genetic approaches.
Although the utility of the SILAC proteomics approach
has already had a major impact in cell biology, it is
worthwhile to consider its potential limitations. For exam-
ple, although metabolic labelling is an effective way to
uniformly incorporate isotopic tags into proteins, in prac-
tice it is not always feasible, as seen with clinical samples
and some model organisms. Also, the ion intensity for each
peptide quantitated by duplex or triplex SILAC is distrib-
uted between several, separate isotopic peaks in the spec-
trum (Figure 2B). This can lower the total number ofpeptide identifications from a given sample owing to the
complexity introduced by the multiple isotopic peaks in the
MS level 1 spectra. This complexity tends to limit the scope
for extensive multiplexing beyond two or three different
conditions in parallel.
An alternative approach is to use a chemical, rather
than metabolic, labelling strategy, which can be applied to
any isolated protein samples, including human clinical
material. Samples are quantified separately, as seen with
a technique such as ICAT (isotope-coded affinity tags) [21]
which attaches an isotope-coded tag to the sulfhydryl
groups of cysteine residues on peptides. This has the
limitation, however, of only labelling peptides that include
cysteine residues. By contrast, dimethyl labelling, which
attaches isotope-substituted formaldehyde to label the
amino termini of peptides and the e-amino groups of
lysines, provides a more efficient and cost-effective strate-
gy for chemical tagging of peptides that may come to be259
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method is that lysine tagging may mask PTMs that spe-
cifically occur on lysine amino acids.
Another variation on the chemical labelling strategy
uses isobaric tags to label isolated peptides, as seen in
techniques such as iTRAQ (isobaric tag for relative and
absolute quantitation) [22] and TMT (tandem mass tags)
[23,24]. Because the tags employed are isobaric, multiple
different labelled samples can be combined for MS analy-
sis, and the separate labelled forms are resolved and
quantitated based on the different reporter ions they gen-
erate after the peptides are fragmented by collisional
dissociation in the mass spectrometer. This has the advan-
tage of allowing a higher degree of multiplexing, with eight
or more different combinations. Hence, complex experi-
ments can be performed and analysed in parallel. For
example, changes in protein levels can be compared at
multiple time-points for both a control and drug-treated
sample. In practice, these isobaric tagging methods have
proven difficult to apply for the accurate quantitation of
proteins in complex biological samples, although recent
improvements in MS instrumentation have helped to
improve this situation.
In comparison with metabolic labelling, all of the meth-
ods described above that are based upon chemical attach-
ment of tags to peptides introduce additional steps in the
analytical strategy that are potential sources of variation
and experimental error. By contrast, metabolic labelling
methods allow separate cell samples to be mixed at an
early stage and proteins isolated simultaneously, and this
helps to improve the accuracy of analysis and quantitation.
In this regard it is interesting that a new method, known as
NeuCode SILAC [25], appears to offer a ‘best of both
worlds’ combination of the SILAC metabolic labelling
strategy with the high multiplexing opportunities of using
multiple isobaric tags. The NeuCode SILAC method
exploits the remarkable efficiency and resolution of the
latest generation of MS instruments to distinguish be-
tween isotopes of similar mass, based upon differences
in nuclear binding energy. Using this approach it has been
possible to grow cells with different forms of lysine substi-
tuted with ‘isotopomers’, each differing in effective mass in
the tens of milliDalton range, and to distinguish and
quantitate peptides derived from these differentially la-
belled proteins.
It is reported that multiplexing by NeuCode SILAC can
detect as many as 12 different isotopomer labels in a
sample, and this could in principle be extended in future
to detection of 20 or more multiplexed samples [25]. The
signal dilution effect encountered in regular SILAC is
avoided in this approach, allowing more efficient detection
and quantitation of peptide ions in the mass spectrometer.
At present, however, the challenge in applying NeuCode
SILAC to cell biology is that it requires pushing the
resolution of current MS instruments to their absolute
limits. It also requires the requisite isotopomer-substitut-
ed amino acids and analytical software to become widely
available to the cell biology community. However, given the
exciting prospect this new technology offers for high multi-
plexing and for accurate and efficient quantitation of pro-
tein levels in many types of complex experiments, we260anticipate that it will become widely adopted in the future.
This will be aided especially when the next generations of
MS instruments arrive that can routinely achieve the high
mass-resolution needed.
Analysis of protein complexes
Most cellular proteins function as components of protein
complexes rather than as single polypeptides. Therefore,
characterisation of the composition and dynamics of mul-
tiprotein complexes is crucial in most areas of cell biology.
A variety of methods and approaches are used to identify
protein interaction partners, typically involving varia-
tions on immunoprecipitation (IP) and affinity pull-down
procedures (Figure 3A), which can be combined with
MudPIT [26,27] to provide a gel-free analytical workflow.
Not only has MS analysis provided a more sensitive way of
detecting coprecipitated proteins in IP experiments, iso-
topic labelling strategies have also provided a powerful
and unbiased methodology for reliably discriminating
specific from non-specific interaction partners in pull-
down experiments [28], as well as providing a convenient
way to distinguish further details of protein complexes.
For example, it can be used to determine isoform-specific
protein interaction partners and to characterise differ-
ences in protein complexes, either under specific condi-
tions, in different subcellular compartments, or after drug
treatments or viral infection.
We expect that the role of MS-based IP experiments
using both label-free and isotopic labelling strategies will
continue to expand in the future. There is also considerable
scope to improve the methodology further, for example by
incorporating additional information when evaluating
whether a coprecipitated protein is likely to be a specific
interaction partner or not. Nonetheless, affinity pull-down
of interacting proteins also has inherent limitations –
including limited ability to resolve multiple related forms
of a complex that share some components and are all
isolated together by IP, but which differ in the presence
of specific subunits and/or different protein isoforms or
PTMs. Affinity purification is also difficult and costly to
adapt for the system-wide analysis of large numbers of
complexes and for the study of changes in protein com-
plexes during different cellular growth conditions and
responses. For system-wide studies, new approaches that
combine large-scale separation of protein complexes in cell
extracts, using either size exclusion chromatography
(SEC) [29,30] or other variants of high performance liquid
chromatography (HPLC) [31], combined with efficient MS-
based protein identification, offer promising ways to char-
acterise protein complexes and their dynamics (Figure 3B).
For example, recent studies have used SEC combined with
MS to study changes in protein complexes in HeLa cyto-
plasmic extracts following epidermal growth factor stimu-
lation [32], and have shown that specific forms of native
complex can be resolved from U2OS cell extracts that are
differentially associated with distinct protein isoforms and
post-translationally modified proteins [33] (Figure 3C).
We expect that further developments of these combined
HPLC-based complex fractionation and MS-proteomics
approaches will find widespread applications throughout
cell biology.
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Figure 3. Approaches to protein interaction analysis. (A) Isotope labelling (e.g., SILAC) has been widely used as a method to discriminate reliably between specific and non-
specific protein interaction partners in immunoprecipitation and affinity pull-down experiments. By measuring the ratio of light (control – e.g., non-specific Ig or no bait
protein) to heavy (e.g., specific Ab or tagged bait protein) isotope-labelled proteins that are copurified and detected by MS analysis, proteins that bind non-specifically will
typically have 1:1 H/L ratios whereas specific interaction partners will have high H/L ratios. Using a triple-labelling strategy this can be extended, for example, by using the
comparison of M/L and H/L isotope ratios to compare specific binding either to different protein isoforms or mutants, or to compare binding in the presence or absence of
an inhibitor, etc. (B) A high-throughput proteomics strategy for analysing protein complexes by (i) first separating protein complexes present in cell extracts using a
chromatography method such as SEC, then (ii) detecting essentially all of the proteins in each resultant SEC fraction following protease digestion and mass spectrometry.
This highlights candidate protein components of complexes based upon coelution profiles across the SEC fractions, and can potentially distinguish complexes containing
either specific protein isoforms and/or PTMs. It can be applied to the system-wide comparison of differences in cellular protein complexes under different growth
conditions, or following drug treatments or other perturbations. (C) An example of a protein, TRXR1_HUMAN, which has multiple isoforms showing differing profiles of
interaction. Abbreviations: Ab, antibody; H/L, heavy/light; Ig, immunoglobulin; M/L, medium/light; PTMs, post-translational modifications; SEC, size exclusion
chromatography; SILAC, stable isotope labelling with amino acids in cell culture.
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There is likely to be continued growth in proteomics pub-
lications as the methods and scope for using MS-based
approaches to address problems in cell biology develop
further. We also anticipate the expansion of quantitative,
‘next-generation’ proteomics strategies for the systematic,
quantitative analysis of protein properties – in other words
the determination of ‘multi-dimensional proteomes’. The
corollary is that the future value of proteomics in cell biology
is closely linked with the need to develop effective, new
strategies for multi-dimensional data analytics and to
cope with the large volumes of proteomics data that will
be generated. This includes the need to build new and more
efficient data-processing pipelines which will be increasing-
ly important to cope with the scale and complexity of future
proteomics data arising from large-scale experiments.Genomics and
RNA data
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262This brings forth several important challenges for the
international research community if we are to exploit fully
the opportunities that proteomics offers cell biology. We
highlight in particular the need to tackle both effective
data sharing, ideally through the creation of freely acces-
sible, user-friendly, online data repositories and the relat-
ed need to integrate proteomics data efficiently with other
published information and with cognate large-scale geno-
mic and transcriptomic data (Figure 4). The utility of
integrated data analysis tools to evaluate and analyse
new results is already seen with online resources such
as PHOSIDA (Phosphorylation Site Database), a PTM
database [34], STRING (Search Tool for the Retrieval of
Interacting Genes) [35], DAVID (Database for Annotation,
Visualisation and Integrated Discovery) [36], and The
Human Protein Atlas [37].Mul-dimensional
proteomics data
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eed to link highly annotated, multi-dimensional proteomics data with information
 publicly available online tools for sharing data related to proteomics are illustrated
otation, Visualisation and Integrated Discovery), The Human Protein Atlas, and the
Review Trends in Cell Biology April 2014, Vol. 24, No. 4There is currently a lack of any coordinated, interna-
tional ‘open data’ strategy in the proteomics community
and this is a situation that we hope will be addressed as a
matter of urgency. Although public repositories are being
developed for depositing raw MS data files, such as the
PRIDE (Proteomics Identifications) database [38] and
more recently CHORUS (Collaborations in HIV Outcomes
Research – US; http://chorusproject.org), we suggest that
this alone will not meet the needs of the cell biology
community. In addition to raw file repositories, cell biolo-
gists require convenient access to searchable databases
providing complex, multi-dimensional proteomics data at
the level of identified protein sequences, including the
measured values of protein properties in different cell
types and under different conditions. The value of such
data will be further increased if entries are extensively
tagged with consistent metadata that can be filtered and
selected.
We have initiated such a scheme by creating a proteo-
mics open data resource, termed the ‘Encyclopedia of
Proteome Dynamics’ (EPD) [13]. The EPD is a searchable
database that provides access to large-scale proteomics
datasets describing subcellular protein localisation, pro-
tein turnover rates, protein complexes, isoform expression
patterns, and PTMs derived from studies on several hu-
man cell lines (http://peptracker.com/epd/). Expanding the
EPD and other similar resources to integrate data from
many different laboratories will require community-led
initiatives to agree on common metadata standards. It will
also require commitment from funding agencies to provide
the resources needed to create and maintain such tools for
effective data integration and sharing.
An advantage to sharing large datasets across the com-
munity in a searchable format, including detailed and
consistent metadata annotations, is the opportunity to
build collections of multi-dimensional data from many
independent experiments. This can be organised to facili-
tate analysis of the whole dataset and cross-correlation
between parameters and measurements recorded in many
separate experiments. However, to integrate and mine
datasets effectively it is imperative that the community
agrees on definitions of metadata terms and how they are
applied, using these terms consistently in publications and
data collections. This would make it much easier and more
accurate to combine large data collections. In this way the
value of the combined data could be greater than the sum of
the conclusions derived from the analysis of any individual
set of experiments – because it allows conclusions to be
reached through the comparison of different result sets.
Thus, the combined data constitute a ‘super-experiment’
that can answer questions that potentially were not con-
ceived during the generation of the individual experimen-
tal datasets contributing to it. For example, it can detect a
difference in protein expression levels, or any other prop-
erties, which consistently correlate with genotypes across
data from multiple different cell lines.
Multi-dimensional proteomics databases can be used to
generate new hypotheses for future evaluation and to test
the feasibility of new ideas against a large collection of
available data. This may already either confirm, or dis-
prove, a new hypothesis or research question without theneed to perform additional experiments, thereby saving
time and research funds. For example, if a model requires
that two or more proteins interact to mediate a particular
response or mechanism, this can be evaluated initially by
checking whether these proteins are detected in the same
subcellular compartments and whether they copurify and/
or cofractionate by SEC analysis. These are data already
available, at least for some human cell lines, in the EPD.
Another example of a ‘super-experiment’ is the Protein
Frequency Library (PFL) (http://peptracker.com/pfl/),
which records data annotating all proteins from many
coimmunoprecipitation experiments [12]. The PFL com-
pares similar datasets, based on their metadata and the
frequency of protein detection, to indicate whether proteins
are specific or non-specific binders – based on the premise
that ‘sticky’ proteins are detected more often than proteins
binding highly selectively to specific target proteins used
as baits.
Concluding remarks
MS-based proteomics technology, which is already of value
for cell biology, has great scope for further expansion and is
poised to deliver major new insights into biological
responses and molecular regulatory mechanisms. Over
the coming years we expect that the increasing availability
of benchtop MS instruments and widening of the expertise
base will allow proteomics to become a standard tool in
many cell biology laboratories rather than remaining the
exclusive domain of specialised facilities. Further improve-
ments in the speed and resolution of MS instruments,
combined with improved experimental design and new
data analysis methods, should help to make proteomics
widely available as an assay tool for quantitating a wide
range of protein properties and responses, and not merely a
means of protein identification. Furthermore, as well as
comparing relative changes in protein levels under differ-
ent conditions, MS-based methods are also being developed
to allow absolute quantitation of protein levels; this will be
extremely useful for building a detailed systems model of
many cellular reactions and in vivo signalling pathways
[39–42].
Proteomics is fast approaching the ability to sample a
‘complete proteome’, whereby a ‘complete proteome’ can be
defined as detection of peptide data for all expressed genes
[43]. However, current proteomics technology still falls
short of the capability to detect full, expressed protein
sequences comprehensively. Thus, even the deepest cover-
age in the most detailed proteomics studies at present
detects less than 50% of the peptides in expressed proteins.
The ability to identify this ‘dark matter’ of the cell prote-
ome promises to reveal exciting new information. For
example, it may reveal peptides with complex PTMs that
contribute to the interactions and regulation of the cognate
proteins. Another interesting opportunity for new techni-
cal advances is in the area of ‘top down’ approaches to MS-
based protein identification. Although most cell biology-
related proteomics work to date has concentrated on the
‘bottom-up’ approach, where proteins are identified indi-
rectly via detection of digested peptide fragments
(Figure 1), it is now becoming feasible to resolve accurately
by MS very large ions that correspond to intact protein263
Review Trends in Cell Biology April 2014, Vol. 24, No. 4molecules [44]. Future generations of mass spectrometers
that extend this capability could thus offer exciting oppor-
tunities for direct protein analyses that could overcome
some of the current limitations and ‘data averaging’ issues
inherent in the bottom-up approach.
Maximising the future value to the cell biological com-
munity of the burgeoning proteomics data mountain
requires new initiatives to promote the effective sharing
and integration of data. We look forward to such develop-
ments, and suggest it would be most effective if led directly
by cell biologists themselves and managed at the interna-
tional community level with stable long-term funding. In
another 15 years, therefore, it may well be that cell biology
students will need to be as familiar with MS instrumenta-
tion and computers as they currently are with microscopes.
Acknowledgements
We thank our colleagues in the Lamond laboratory for helpful sugges-
tions on the manuscript and to our collaborators in the European
Commission Framework Program 7 (FP7) Prospects network (Grant:
HEALTH-F4-2008-201648) for many fruitful interactions and discus-
sions. A.I.L. is a Wellcome Trust Principal Research Fellow.
References
1 Lamond, A.I. and Mann, M. (1997) Cell biology and the genome projects
a concerted strategy for characterizing multiprotein complexes by
using mass spectrometry. Trends Cell Biol. 7, 139–142
2 Eng, J. et al. (1994) An approach to correlate tandem mass spectral
data of peptides with amino acid sequences in a protein database. J.
Am. Soc. Mass Spectrom. 5, 976–989
3 Craig, R. and Beavis, R.C. (2004) TANDEM: matching proteins with
tandem mass spectra. Bioinformatics 20, 1466–1467
4 Perkins, D.N. et al. (1999) Probability-based protein identification by
searching sequence databases using mass spectrometry data.
Electrophoresis 20, 3551–3567
5 Cox, J. et al. (2011) Andromeda: a peptide search engine integrated into
the MaxQuant environment. J. Proteome Res. 10, 1794–1805
6 Moorhead, G.B. et al. (2007) Emerging roles of nuclear protein
phosphatases. Nat. Rev. Mol. Cell Biol. 8, 234–244
7 Maier, T. et al. (2009) Correlation of mRNA and protein in complex
biological samples. FEBS Lett. 583, 3966–3973
8 Andersen, J.S. et al. (2002) Directed proteomic analysis of the human
nucleolus. Curr. Biol. 12, 1–11
9 Andersen, J.S. et al. (2005) Nucleolar proteome dynamics. Nature 433,
77–83
10 McClatchy, D.B. et al. (2007) Quantification of the synaptosomal
proteome of the rat cerebellum during post-natal development.
Genome Res. 17, 1378–1388
11 Boisvert, F-M. et al. (2012) A quantitative spatial proteomics analysis
of proteome turnover in human cells. Mol. Cell. Proteomics 11,
M111.011429
12 Boulon, S. et al. (2010) Establishment of a protein frequency library
and its application in the reliable identification of specific protein
interaction partners. Mol. Cell. Proteomics 9, 861–879
13 Larance, M. et al. (2013) Global subcellular characterization of protein
degradation using quantitative proteomics. Mol. Cell. Proteomics 12,
638–650
14 Trinkle-Mulcahy, L. et al. (2006) Repo-Man recruits PP1 gamma to
chromatin and is essential for cell viability. J. Cell Biol. 172, 679–692
15 Oda, Y. et al. (1999) Accurate quantitation of protein expression and site-
specific phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 96, 6591–6596
16 Lahm, H.W. and Langen, H. (2000) Mass spectrometry: a tool for
the identification of proteins separated by gels. Electrophoresis 21,
2105–2114
17 Ong, S-E. et al. (2002) Stable isotope labeling by amino acids in cell
culture, SILAC, as a simple and accurate approach to expression
proteomics. Mol. Cell. Proteomics 1, 376–386
18 Mann, M. (2006) Functional and quantitative proteomics using SILAC.
Nat. Rev. Mol. Cell Biol. 7, 952–95826419 Kirchner, M. and Selbach, M. (2012) In vivo quantitative proteome
profiling: planning and evaluation of SILAC experiments. Methods
Mol. Biol. 893, 175–199
20 Wu, C.C. et al. (2004) Metabolic labeling of mammalian organisms with
stable isotopes for quantitative proteomic analysis. Anal. Chem. 76,
4951–4959
21 Gygi, S.P. et al. (1999) Quantitative analysis of complex protein
mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17,
994–999
22 Ross, P.L. et al. (2004) Multiplexed protein quantitation in
Saccharomyces cerevisiae using amine-reactive isobaric tagging
reagents. Mol. Cell. Proteomics 3, 1154–1169
23 Thompson, A. et al. (2003) Tandem mass tags: a novel quantification
strategy for comparative analysis of complex protein mixtures by MS/
MS. Anal. Chem. 75, 1895–1904
24 Everley, R.A. et al. (2013) Increasing throughput in targeted
proteomics assays: 54-plex quantitation in a single mass
spectrometry run. Anal. Chem. 85, 5340–5346
25 Hebert, A.S. et al. (2013) Neutron-encoded mass signatures for
multiplexed proteome quantification. Nat. Methods 10, 332–334
26 Wolters, D.A. et al. (2001) An automated multidimensional protein
identification technology for shotgun proteomics. Anal. Chem. 73,
5683–5690
27 Washburn, M.P. et al. (2001) Large-scale analysis of the yeast proteome
by multidimensional protein identification technology. Nat. Biotechnol.
19, 242–247
28 Trinkle-Mulcahy, L. et al. (2008) Identifying specific protein interaction
partners using quantitative mass spectrometry and bead proteomes. J.
Cell Biol. 183, 223–239
29 Wheaton, R.M. and Bauman, W.C. (1953) Non-ionic separations with
ion exchange resins. Ann. N. Y. Acad. Sci. 57, 159–176
30 Olinares, P.D. et al. (2010) Megadalton complexes in the chloroplast
stroma of Arabidopsis thaliana characterized by size exclusion
chromatography, mass spectrometry, and hierarchical clustering.
Mol. Cell. Proteomics 9, 1594–1615
31 Havugimana, P.C. et al. (2012) A census of human soluble protein
complexes. Cell 150, 1068–1081
32 Kristensen, A.R. et al. (2012) A high-throughput approach for
measuring temporal changes in the interactome. Nat. Methods 9,
907–909
33 Kirkwood, K.J. et al. (2013) characterisation of native protein
complexes and protein isoform variation using size-fractionation
based quantitative proteomics. Mol. Cell. Proteomics http://
dx.doi.org/10.1074/mcp.M113.032367
34 Gnad, F. et al. (2011) PHOSIDA 2011: the posttranslational
modification database. Nucleic Acids Res. 39, D253–D260
35 Szklarczyk, D. et al. (2010) The STRING database in 2011: functional
interaction networks of proteins, globally integrated and scored.
Nucleic Acids Res. 39, D561–D568
36 Da Wei, H. et al. (2008) Systematic and integrative analysis of large
gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57
37 Uhlen, M. et al. (2010) Towards a knowledge-based Human Protein
Atlas. Nat. Biotechnol. 28, 1248–1250
38 Vizcaino, J.A. et al. (2013) The PRoteomics IDEntifications (PRIDE)
database and associated tools: status in 2013. Nucleic Acids Res. 41,
D1063–D1069
39 Zeiler, M. et al. (2012) A Protein Epitope Signature Tag (PrEST) library
allows SILAC-based absolute quantification and multiplexed
determination of protein copy numbers in cell lines. Mol. Cell.
Proteomics 11, O111.009613
40 Picotti, P. and Aebersold, R. (2012) Selected reaction monitoring-based
proteomics: workflows, potential, pitfalls and future directions. Nat.
Methods 9, 555–566
41 Beynon, R.J. et al. (2005) Multiplexed absolute quantification in
proteomics using artificial QCAT proteins of concatenated signature
peptides. Nat. Methods 2, 587–589
42 Gerber, S.A. et al. (2003) Absolute quantification of proteins and
phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad.
Sci. U.S.A. 100, 6940–6945
43 Mann, M. et al. (2013) The coming age of complete, accurate, and
ubiquitous proteomes. Mol. Cell 49, 583–590
44 Marcoux, J. and Robinson, C.V. (2013) Twenty years of gas phase
structural biology. Structure 21, 1541–1550
